New biomaterials present opportunities to develop new devices and treatment methods
This article was originally published in Clinica
Exciting new biomaterials could radically change the way many common medical conditions are treated. Peter Charlish reports from a meeting in London where scientists and industry representatives discussed the device of the future.
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.